Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- BTIG raised the price target for Rapport Therapeutics Inc (NASDAQ:RAPP) from $65 to $75. BTIG analyst Kambiz Yazdi maintained a Buy rating. Rapport Therapeutics shares closed at $42.68 on Tuesday. See how other analysts view this stock.
- Ascendiant Capital boosted Allarity Therapeutics Inc (NASDAQ:ALLR) price target from $10.25 to $11. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Allarity Therapeutics shares closed at $1.11 on Tuesday. See how other analysts view this stock.
- Itau BBA cut price target for Nu Holdings Ltd. (NYSE:NU) from $20 to $18. Itau BBA analyst Pedro Leduc downgraded the stock from Outperform to Market Perform. Nu Holdings shares closed at $14.19 on Tuesday. See how other analysts view this stock.
- UBS raised the price target for Union Pacific Corp (NYSE:UNP) from $310 to $339. UBS analyst Thomas Wadewitz upgraded the stock from Neutral to Buy. Union Pacific shares closed at $283.99 on Tuesday. See how other analysts view this stock.
- Barclays cut Cellectis SA (NASDAQ:CLLS) price target from $9 to $1.3. Barclays analyst Lukas Shumway downgraded the stock from Overweight to Underweight. Cellectis shares closed at $1.61 on Tuesday. See how other analysts view this stock.
- Wells Fargo slashed J B Hunt Transport Services Inc (NASDAQ:JBHT) price target from $335 to $305. Wells Fargo analyst Christian Wetherbee maintained an Overweight rating. J B Hunt Transport shares closed at $273.05 on Tuesday. See how other analysts view this stock.
- Barclays increased Alvotech SA (NASDAQ:ALVO) price target from $4 to $8. Barclays analyst Glen Santangelo upgraded the stock from Underweight to Overweight. Alvotech shares closed at $5.02 on Tuesday. See how other analysts view this stock.
- Wells Fargo raised the price target for Disc Medicine Inc (NASDAQ:IRON) from $79 to $86. Wells Fargo analyst Derek Archila maintained an Overweight rating. Disc Medicine shares closed at $67.30 on Tuesday. See how other analysts view this stock.
- Barclays cut Carnival Corporation Ltd (NYSE:CCL) price target from $35 to $33. Barclays analyst Brandt Montour maintained an Overweight rating. Carnival shares closed at $22.11 on Tuesday. See how other analysts view this stock.
- Baird raised Workiva Inc (NYSE:WK) price target from $95 to $105. Baird analyst Rob Oliver maintained an Outperform rating. Workiva shares closed at $74.81 on Tuesday. See how other analysts view this stock.
Considering buying CCL stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment